Preservation of Eumelanin Hair Pigmentation in Proopiomelanocortin-Deficient Mice on a Nonagouti (a/a) Genetic Background by Slominski, Andrzej et al.
Digital Commons @ George Fox University
Faculty Publications - Department of Biology and
Chemistry Department of Biology and Chemistry
2005
Preservation of Eumelanin Hair Pigmentation in
Proopiomelanocortin-Deficient Mice on a
Nonagouti (a/a) Genetic Background
Andrzej Slominski
University of Tennessee
Przemyslaw M. Plonka
Jagiellonian University Cracow
Alexander Pisarchik
Jagiellonian University Cracow
James L. Smart
George Fox University, jsmart@georgefox.edu
Virgine Tolle
Oregon Health and Science University
See next page for additional authors
Follow this and additional works at: http://digitalcommons.georgefox.edu/bio_fac
Part of the Biology Commons, Chemistry Commons, and the Endocrinology Commons
This Article is brought to you for free and open access by the Department of Biology and Chemistry at Digital Commons @ George Fox University. It
has been accepted for inclusion in Faculty Publications - Department of Biology and Chemistry by an authorized administrator of Digital Commons @
George Fox University. For more information, please contact arolfe@georgefox.edu.
Recommended Citation
Previously published in Endocrinology, 2005, vol. 146, pp. 1245–1253 http://press.endocrine.org/doi/full/10.1210/en.2004-0733
Authors
Andrzej Slominski, Przemyslaw M. Plonka, Alexander Pisarchik, James L. Smart, Virgine Tolle, Jacobo
Wortsman, and Malcolm J. Low
This article is available at Digital Commons @ George Fox University: http://digitalcommons.georgefox.edu/bio_fac/63
Preservation of Eumelanin Hair Pigmentation in
Proopiomelanocortin-Deficient Mice on a Nonagouti
(a/a) Genetic Background
Andrzej Slominski, Przemyslaw M. Plonka, Alexander Pisarchik, James L. Smart, Virginie Tolle,
Jacobo Wortsman, and Malcolm J. Low
Department of Pathology and Laboratory Medicine (A.S., A.P.), University of Tennessee, Memphis, Tennessee 38163;
Department of Biophysics (P.M.P.), Faculty of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; Vollum
Institute (J.L.S., V.T., M.J.L.), Department of Behavioral Neuroscience (M.J.L.), and Center for the Study of Weight
Regulation and Associated Disorders (M.J.L.), Oregon Health and Science University, Portland, Oregon 97239; and
Department of Medicine (J.W.), Southern Illinois University, Springfield, Illinois 62704
The original strain of proopiomelanocortin (POMC)-deficient
mice (Pomc/) was generated by homologous recombination
in 129X1/SvJ (Aw/Aw)-derived embryonic stem cells using a
targeting construct that deleted exon 3, encoding all the
known functional POMC-derived peptides including MSH,
from the Pomc gene. Although these Pomc/ mice exhibited
adrenal hypoplasia and obesity similar to the syndrome of
POMC deficiency in children, their agouti coat color was only
subtly altered. To further investigate the mechanism of hair
pigmentation in the absence of POMC peptides, we studied
wild-type (Pomc/), heterozygous (Pomc/), and homozy-
gous (Pomc/) mice on a nonagouti (a/a) 129;B6 hybrid ge-
netic background. All three genotypes had similar black fur
pigmentation with yellow hairs behind the ears, around the
nipples, and in the perianal area characteristic of inbred
C57BL/6 mice. Histologic and electron paramagnetic reso-
nance spectrometry examination demonstrated that hair fol-
licles in back skin of Pomc/ mice developed with normal
structure and eumelanin pigmentation; corresponding mo-
lecular analyses, however, excluded local productionofMSH
and ACTH because neither Pomc nor putative Pomc pseudo-
genemRNAsweredetected in the skin. Thus, 129;B6Pomcnull
mutantmice produce abundant eumelanin hair pigmentation
despite their congenital absence of melanocortin ligands.
These results suggest that either the mouse melanocortin re-
ceptor 1 has sufficient basal activity to trigger and sustain
eumelanogenesis in vivo or that redundant nonmelanocortin
pathway(s) compensate for the melanocortin deficiency.
Whereas the latter implies feedback control ofmelanogenesis,
it is also possible that the two mechanisms operate jointly in
hair follicles.
MELANINBIOSYNTHESIS IS initiated both in vitro andin vivo from the obligatory hydroxylation of l-
tyrosine to l-dihydroxyphenylalanine (L-DOPA), catalyzed
by tyrosinase (EC 1.14.18.1) (1–3). Once L-DOPA is formed,
further steps of melanogenesis consisting of a series of oxi-
doreduction reactions and intramolecular transformations
can occur spontaneously and at varying rates, depending on
local concentrations of hydrogen ions, metal cations, reduc-
ing agents, thiols, and oxygen (1). Eumelanogenesis involves
the transformation of dopaquinone to leukodopachrome, fol-
lowed by a series of oxidoreduction reactions with produc-
tion of the intermediates dihydroxyindole and dihydroxy-
indole carboxylic acid, which undergo polymerization to
form eumelanin (1, 4, 5). Pheomelanogenesis also starts with
dopaquinone, which is conjugated to cysteine or glutathione
to yield cysteinyldopa and glutathionyldopa for further
transformation into pheomelanin (1, 5, 6).
Although tyrosinase activity is the rate-limiting step
among the melanogenesis-related enzymes (1, 7, 8), pig-
mentation is under complex genetic control regulated by
more than 150 alleles representing more than 90 gene loci
(3, 9 –14). Protein products of these loci include enzymes,
structural proteins, transcriptional regulators, transport-
ers, receptors, and growth factors with a wide array of
functions and cellular targets (3, 13). Among them are the
important structural, enzymatic and regulatory proteins
coded by albino(c)/TYR, brown(b)/TYRP1, slaty(slt)/TYRP2/
DCT, silver(slt)/SILV, pink-eyed dilute(p)/P/OCA2, under-
white(uw)/LOC51151, MART1, OA1 loci, melanocortin recep-
tor type 1 (MC1-R), proopiomelanocortin (POMC), and agouti
(AGP) (3, 13).
The melanogenic effects of POMC-derived MSH and
ACTH peptides have been documented in a number of ver-
tebrate species (3, 13, 15, 16). Thus, in amphibians - and
MSH induce darkening of the skin (reviewed in Ref. 16),
whereas in mammalian systems such as rodents, MSH pep-
tides stimulate both melanogenesis and the switch from
pheo- (yellow/red) to eumelanogenic (black) pathways (13,
17–22). In humans the systemic administration of MSH,
MSH, or ACTH stimulates skin pigmentation, predomi-
nantly in sun-exposed areas, whereas pathologically in-
creased plasma ACTH levels (Addison’s disease or Nelson’s
Abbreviations: AGP, Agouti protein; DPPH, 1,1-diphenyl-2-picrylhy-
drazyl; EPR, electron paramagnetic resonance; GAPDH, glyceraldehyde-
3-phosphate dehydrogenase; L-DOPA, l-dihydroxyphenylalanine; MC1-
R,melanocortin receptor type 1; POMC, proopiomelanocortin; RT, reverse
transcription.
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syndrome) induce hyperpigmentation and skin atrophy (15).
Conversely, patients with POMC gene mutations leading to
defective production of the POMC prohormone in all tissues
show a red hair phenotype in addition to early-onset obesity
and adrenal insufficiency (23). Recessive mutations in the
MC1-R that produce unresponsiveness of epidermal mela-
nocytes to MSH also result in the red hair phenotype (13,
24) in humans or yellow fur in mice, whereas a dominant
allele produces a constitutively active MC1-R that results in
uniform jet black fur in somber mice (25).
Agouti coloration in wild-type mice is characterized by a
banded pigmentation pattern of the pelage, in which each
hair is black with a subapical band of yellow. AGP (the
product of agouti locusA) is produced in dermal papilla cells
and acts within the microenvironment of the hair follicle
during hair growth to transiently switch eumelanin synthesis
into pheomelanin synthesis, thereby generating the agouti
coat color (12, 26–28). Several studies have demonstrated
that AGP can function as a competitive antagonist of the
MC1-R, blocking its activation by MSH (3, 13, 26) or as an
inverse agonist (29, 30). AGP therefore suppresses melano-
genesis by decreasing tyrosinase activity, decreasing expres-
sion of melanogenic genes including those that encode
tyrosinase and tyrosinase-related protein 1 and 2 and inhib-
iting translation of MC1-R (3, 13, 31).
Melanocortin and ACTH sequences are encoded within
exon 3 of the Pomc gene (32), which in addition to the pitu-
itary, is transcribed, translated, and processed in the central
nervous system (33) and a variety of peripheral tissues in-
cluding skin (15). Concordantly, two distinct strains of Pomc-
null mice generated independently on either a hybrid 129X1;
129S6 genetic background (34) or a 129S6;129S2 genetic
background (35) exhibit a syndrome of adrenal insufficiency,
obesity, and a subtle alteration in coat color distinguished by
a lighter yellow tint to agouti-banded hairs that is most
pronounced on their bellies. However, when the null Pomc
allele was backcrossed from the 129X1;129S6 white-bellied
agouti genetic background (Aw/Aw) onto the C57BL/6J non-
agouti (a/a), genetic background for two generations the
Pomc/ offspring exhibited black fur pigmentation visually
indistinguishable from sibling controls expressing the wild-
type Pomc allele (36). This persistence of black pigmentation
contrasts with the red hair phenotype of human POMC de-
ficiency (23). It is also at variance with our own observations
in the C57BL/6 mouse strain of anagen coupling to mela-
nogenesis and enhanced cutaneous expression of the Pomc
and Mc1r genes (15, 37, 38). Therefore, we performed de-
tailed histological studies of skin and hair follicle structure
with biophysical analyses of the pigment type produced in
Pomc/ mice. The results were then correlated with molec-
ular analyses of local POMC expression.
Materials and Methods
Animals
The mutant Pomc allele designed to delete exon 3 of the gene, which
encodes all the known functional peptides, was originally constructed
and targeted into strain 129X1/SvJ (Aw/Aw pTyrc-ch/ pTyrc)-derived RW-4
embryonic stem cells by Yaswen et al. (34) and then subsequently carried
on a hybrid 129X1;129S6 genetic background (Aw/Aw /?). After two
sequential generations of backcrossing the mutant Pomc allele onto the
C57BL/6J (a/a/) background (The Jackson Laboratory, Bar Harbor,
ME), a colony of hybrid 129;B6 mice (approximately 75% of alleles from
B6) was established in Portland, and all experimental animals were
derived from heterozygous breeding pairs of mice with genotypes
(Pomc/ a/a/). Mice were genotyped at the Pomc locus by PCR using
two oligonucleotide primer pairs: 5-GCTTGCATCCGGGCTTG-
CAAACT-3 and 5-AGCAACGTTGGGGTACACCTTC-3 amplify a
318-bp wild-type allele; 5-TTGTTAACTTGTTTATTGCAGCTT-3 and
318-bp 5-ATGAGAAATTGGGCCATGGGACTGAC-3 amplify an ap-
proximately 300-bpmutant allele. All procedureswithmice followed the
recommendations in the National Institutes of Health Public Health
Service Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee at Or-
egon Health and Science University.
Tissue processing
Murine tissue samples consisted of skin isolated at telogen and ana-
gen (d 5 to 7 post depilation) stages of the hair cycle. The animals (9
month old male mice) were euthanized under 2% Avertin (2,2,2-tribro-
moethanol) anesthesia, and back skin was collected following protocols
routinely used in our laboratory. Tissue specimens were either frozen
rapidly in liquid nitrogen and stored at 80 C until further analysis or
fixed in 10% buffered formalin, paraffin embedded, and stained with
hematoxylin and eosin (38).
Preparation of samples for electron paramagnetic resonance
(EPR) assay
Fur was obtained from the back of anesthetized adult mice using an
electric clipper, collected into individual preweighed polypropylene
tubes, and stored dry at room temperature until analysis. We compared
fur of test mice (either Pomc/ or Pomc/) with fur of standard black
C57BL/6J mice containing eumelanin and with samples of yellow fur
containing pheomelanin, i.e.C57BL/6JAY/amice (39, 40), and the yellow
formofMongolian gerbil (Meriones unguiculatus) (41).We also compared
the EPR signals of fur with the signals of synthetic melanins.
Dopa-melanin, the synthetic counterpart of eumelanin, was synthe-
sized by dopa autooxidation (42). The aqueous solution of d,l-dopa was
bubbled with air for 4 d at ambient temperature, whereas the pH was
kept constant at 8.0 (NH4OH). The synthetic equivalent for a natural
pheomelanin was prepared by enzymatic oxidation of L-DOPA and
l-cysteine (according to Ref. 43). The solution of 994 mg L-DOPA and
a double excess of l-cysteine (448 mg) in 500 ml Sorensen’s buffer
[Na2HPO4/KH2PO4, 0.01m (pH 6.8)] was supplemented with 200,000 U
of yeast tyrosinase in 25 ml of the same buffer, stirred for 1 h, and
bubbled for 4 d with air. Both melanins were then precipitated from
solution by lowering the pH to 3.0–3.5 with concentrated HCl, purified
with several washings with redistilled water, and dialyzed against re-
distilled water for 4 d. The substances were then dried for 4 d in the air
at 37 C and introduced into glass capillaries that were sealed by melting
and solidifying their ends. Every sample contained 8.2  0.1 mg of dry
powdered melanin. All the reagents were obtained from Sigma Chem-
ical Co. (St. Louis, MO).
EPR spectrometry
All the measurements were carried out at room temperature using a
Varian 103 EPR X-band spectrometer (Varian, Inc., Palo Alto, CA) with
100 kHzmodulation frequency and a rectangular TE 102 resonant cavity.
Samples of fur (20  1 mg) and capillaries with melanins were put into
a quartz finger Dewar and then always placed in the cavity in the same
position against themodulation field. Parameters ofmeasurementswere
as follows: magnetic field 3265  50 Gs; modulation amplitude 5 Gs for
quantitative comparisons; 2 Gs to record the signal shape; and 0.5 Gs to
measure the signal peak-to-peakwidth, microwave frequency 9.17 GHz,
and power 1 mW. Spectra were acquired in a digital form (1024 points
per scan) at 0.1 or 0.3 time constant, 90–180 time scan, 1–7 times (av-
eraged), at instrumental gain 12,500 to1 million according to the par-
ticular signal to noise ratio. All the signal intensities were expressed as
integral intensities (by double integration of signal curves), whereupon
means  sem of at least five independent samples were calculated to
prepare bar plots. The quantitative data were additionally recalculated
1246 Endocrinology, March 2005, 146(3):1245–1253 Slominski et al. • Eumelanin Production and POMC Deficiency
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 09 April 2015. at 10:06 For personal use only. No other uses without permission. . All rights reserved.
for a constant gain (12,500) and constant sample mass (20 mg). All the
conclusions drawn from the comparisons of the integral intensities were
additionally confirmed by comparing peak-to-peak amplitudes of the
signals. A small powder sample of 1,1-diphenyl-2-picrylhydrazyl
(DPPH) served as amarker for the position of the free radical signal (g
2.0037). The statistical significance of the differences in signal intensities
andwidths were tested by the independent two-tailed Student t test and
accepted for P  0.05.
cDNA preparation
Total RNA was extracted using a Trizol isolation kit (Life Technol-
ogies, Inc.-BRL, Gaithersburg, MD), whereas poly (A) mRNA was
isolated using Oligotex mRNA minikit (Qiagen, Valencia, CA). RNA
samples were treated with DNase before reverse transcription (RT), and
only those samples that were negative for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) genomic sequences by PCR amplification
were used for RT (44). The synthesis of first-strand cDNAwasperformed
using the Superscript preamplification system (Invitrogen, Carlsbad,
CA). An aliquot of 5 g total RNA or 0.1 g mRNA per reaction was
reverse transcribed using oligo(dT) as the primer. The expression of
genes having only one coding exon was evaluated using cDNA syn-
thesized from DNase-treated RNA. Lack of DNA contamination was
confirmed by negative amplification of RNA without prior RT.
PCRs
All primers were synthesized by Integrated DNA Technology Inc.
(Coralville, IA). All samples were standardized by the amplification of
the housekeeping gene GAPDH as described previously (44).
Detection of mouse Pomc and Pomc-ps1 pseudogene was obtained by
direct or nested PCR amplifications of the corresponding cDNAs. Se-
quences of the primers used for PCR amplifications are listed in Table
1, whereas their exon location together with gene structure is presented
in Fig. 1. The reaction mixture (25 l) contained 3.0 mmMgCl2, 0.25 mm
of each deoxynucleotide triphosphate, 0.4 m of each primer, 75 mm
Tris-HCl (pH 8.8), 20 mm (NH4)2SO4, 0.01% Tween 20, and 1.25 U of Taq
polymerase (Promega, Madison, WI). The mixture was heated to 95 C
for 3 min and then amplified for 35 cycles as specified: 94 C for 30 sec
(denaturation), 55 C for 30 sec (annealing), and 72 C for 40 sec (exten-
sion). Amplification products were separated by agarose gel electro-
phoresis and visualized by ethidium bromide staining according to
standard protocols used in our laboratory (44). For nested PCR the
mixtures were amplified for 25 cycles as described above during the first
round of amplification. Five microliters were used for a second cycle of
amplification using primers described in Table 1 and the program de-
scribed above.
Sequencing
The identified PCR products were excised from the agarose gel and
purified by GFX PCR DNA and gel band purification kit (Amersham
Pharmacia Biotech, Piscataway, NJ). PCR fragments were cloned in
pGEM-Teasy vector according to the protocol of the manufacturer (Pro-
mega). Plasmid DNA was purified by a plasmid minikit (Qiagen). Se-
quencing was performed in the Molecular Resource Center at the Uni-
versity of Tennessee Health Science Center (Memphis) using the 3100
genetic analyzer (Applied Biosystems, Foster City, CA) and BigDye
terminator kit.
Results
The Pomc/ mutant mice described by Yaswen et al. (34)
were generated originally on a hybrid 129X1;129S6 genetic
background (Aw/Aw/?). Therefore, thesemice were homozy-
gous for the white-bellied agouti allele (Aw/Aw) and either
homozygous for the wild-type Tyrosinase allele (/) or het-
erozygous for one of the recessive Tyrosinase alleles pink-
eyed chinchilla (/pTyrc-ch) or pink-eyed albino (/pTyrc)
present in the genome of the RW4 embryonic stem cells that
were used for POMC gene targeting by homologous recom-
bination. We further evaluated the contribution of the
Pomc/ genotype to hair follicle pigmentation after back-
crossing the null Pomc allele for two generations onto the
nonagouti C57BL/6J (a/a/) genetic background.
AllN1 heterozygous 129;B6 (Pomc
/Aw/a/?)mice had fur
pigmentation characteristic for expression of the dominant
Aw and wild-type Tyrosinase alleles: dark agouti hairs on the
back and lighter white/yellow hairs on the belly. In contrast,
one fourth of the N2 heterozygous Pomc mice had black fur
consistent with a (Pomc/ a/a /?) genotype and the remain-
ing three fourths all had coat coloring identical with the
agouti N1 generation mice. Intercrossing of black N2 het-
erozygousPomcmice yielded offspringwith each of the three
possible Pomc genotypes, all of which had indistinguishable
black fur pigmentation with scattered yellow hairs behind
the ears on the ventral surface of the neck, around the nip-
ples, and in the perianal area (Fig. 2, A–H).Nomicewith pink
eyes and chinchilla or albino fur have been found of a total
population of more than 500 born to multiple N2 heterozy-
gous Pomc breeder pairs, indicating with virtual certainty
that the recessive pTyrc-ch and pTyrc alleles were eliminated
from our breeding colony by segregation at an earlier gen-
eration and therefore that all the mice studied must be
homozygous for the wild-type Tyrosinase allele. The same
phenotype of uniformly black fur was observed after syn-
FIG. 1. Exon location of primers used to am-
plify mouse Pomc cDNA from skin. Primer
sequences are provided in Table 1.
TABLE 1. PCR amplification of the mouse Pomc gene and Pomc-ps1 pseudogene
Primer location
PCR1 PCR2 (nested)
Primer name Primer sequence Fragment size (bp) Primer name Primer sequence Fragment size (bp)
Exons 2 and 3 P327 GTGGAAGATGCCGAGATTCTG 746 P328 TCCTGCTTCAGACCTCCATAG 641
P326 GGGGCCTTGGAATGAGAAGAC P330 GTTCTTGATGATGGCGTTCTTG
Exons 2 and 3 P328 TCCTGCTTCAGACCTCCATAG 693 P329 CTGGCAACGGAGATGAACAG 504
P326 GGGGCCTTGGAATGAGAAGAC P330 GTTCTTGATGATGGCGTTCTTG
Exon 3 P329 CTGGCAACGGAGATGAACAG 555 P325 CCCAGGAACAGCAGCAGTG 424
P326 GGGGCCTTGGAATGAGAAGAC P330 GTTCTTGATGATGGCGTTCTTG
Pseudogene P331 ACTAATTTCAAGGAGGTTTTCT 279
P332 GACGTGCTCCAAGCCATCAG
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chronous anagen induction by hair depilation in Pomc/
and Pomc/ mice (Fig. 2, I and J).
Morphological examination showed almost identical histo-
architecture in skin from Pomc/ and Pomc/mice at telogen
and anagen phases of hair growth mice (Fig. 3, A-D). Thus, the
epidermis and dermis with its adnexal structures had the same
characteristic features as those described previously in the con-
trol C57BL/6J mice (38). Furthermore, Pomc/ mice showed
normally developing anagen hair follicles with identical struc-
ture to that observed in Pomc/ and C57BL/6J control mice
(Fig. 3, E and F, left panels). The hair follicles were melanogeni-
cally active producing black hair shafts with a characteristic
banding (Fig. 3, E and F, right inset panels).
Hair shafts obtained from Pomc/ mice, as well as from
Pomc/ and C57BL/6J (a/a) mice, were all homogenously
black and revealed a slightly asymmetric singlet EPR signal
placed around g 2.0037 (Fig. 4). This singlet corresponded
to a DPPH-free radical standard and had a similar shape as
the signal of synthetic dopa melanin (Fig. 4). The hair sam-
ples also revealed very similar widths of the EPR lines, ap-
proximately 0.5 Gs higher than the synthetic dopa melanin
signals (4.7Gs vs. 4.2Gs). The othermaterials analyzed in this
study, i.e. synthetic cysteinyldopa melanin, fur of C57BL/6J
(AY/a), and fur of yellow gerbils, exhibited EPR signals with
clear hyperfine structure connected to the location of un-
paired electrons near the nucleus of 14N (41, 45, 46). These
pheomelanin-containingmaterials also revealedmuchwider
EPR signals (approximately 6–7 Gs), compared with black
fur and synthetic dopa melanin (Fig. 5B, P  103 to P 
105). Quantitative analyses of eumelanin were also per-
formed (Fig. 5A). As expected, the EPR signal intensity was
lower by at least of 1 order of magnitude (P  103 to P 
106) in furs of obese yellow Ay/a mice and yellow gerbils,
which produced pheomelanin, than the black furs. The syn-
thetic cysteinyldopamelanin revealed an approximately 50%
lower EPR signal than dopa melanin (Fig. 5A). Interestingly,
the genetically manipulated 129;B6 mice tended to have
lower eumelanin content than pure C57BL/6J (Fig. 5), but
there was no statistically significant difference between the
hybrid 129;B6 Pomc/ and C57BL/6J mice.
The presence of a hyperfine structure of the EPR signal of
pigments containing a contribution of pheomelanin origi-
nates from the difference in the chemical character of
pheomelanin-like paramagnetic centers being of a semiqui-
nonimine rather than semiquinone character (43) and is con-
sidered a sine qua non for the presence of pheomelanin in
biological samples (47). Conversely, the lack of this structure
in a signal strongly suggests the lack of pheomelanin in an
investigated material but does not represent an absolute
proof because trace amounts of pheomelanin might be ef-
fectively masked by a strong eumelanin-like signal. Never-
theless, other differences in the signal satisfactorily supple-
ment the notion that the Pomc null mutation did not result in
any substantial pheomelanogenesis in ourmodel because the
black furs differed only slightly in their EPR signal intensity
(Fig. 5A) but not in their peak-to-peak widths (Fig. 5B). In
contrast, the pheomelanin-containing furs always revealed
an EPR signal of at least 1 order ofmagnitude lower intensity,
consistent with other studies on the chemical method of
pheomelanin estimation (39, 40). The higher values of the
signal peak-to-peak width of natural pigments in compari-
son with their synthetic counterparts (Fig. 5B) is not surpris-
ing due to the constitutive presence of some amounts of
paramagnetic metal ions (iron, copper, manganese) in nat-
ural melanins (48). However, the pheomelanin-like signals
are always wider than the ones of eumelanins (45) (see cys-
teinyldopa vs. dopa melanin or pheomelanin-containing fur
vs. black fur signals in Fig. 5B). Judging by the line width and
FIG. 2. Pigmentary phenotype of experimental mice. Dorsal (A) and
ventral (B) views of 3-month-old sibling female Pomc/ (upper) and
Pomc/ (lower) mice. Detailed views of the head (C and D), dorsal
surface of ears (E and F), and ventral surface of neck (G and H) of
9-month-old sibling male Pomc/ (C, E, and G) and Pomc/ (D, F,
and H) mice. Telogen hairs and adjacent anagen V skin (7 d after
depilation) with regrowing hairs on the back of 9-month-old sibling
male Pomc/ (I) and Pomc/ (J) mice.
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the lack of hyperfine structure, all the pigments of the in-
vestigated black furs, including Pomc/ and C57BL/6J-
derived hair shafts, revealed EPR signals of very similar
shapes, betraying a prominent homogeneity of the popula-
tion of corresponding paramagnetic centers. If the Pomc/
mice or wild-type Pomc/ mice contain any traces of
pheomelanin that cannot bedetected byEPR, their contribution
to the resultingparamagnetismofpigmentswouldbenobigger
than that in the eumelanin-containing C57BL/6J mice.
To test for the possibility of residual local production of
MSH and ACTH in the Pomc/ mice, we performed
molecular analyses for Pomc gene expression in back skin
(Fig. 6). Neither direct nor nested RT-PCR with primers at
exons 2 vs. 3 or solely at exon 3 could detect POMCmRNA
in back skin from 129;B6 Pomc/mice (Fig. 6). Predictably,
POMC mRNA was detected in the skin of sibling control
129;B6 Pomc/ and Pomc/mice. Sequencing of the PCR-
amplified DNA products from the latter mice confirmed
their identity as transcripts from the Pomc gene (data not
shown). As a further control, POMC mRNA was also de-
tected in the skin of mice generated by crossing a 10-kb
Pomc transgene containing 2 kb of promoter sequences and
the intact transcriptional unit (Smart, J. L., V. S. Tolle, and
M. J. Low, manuscript in preparation) onto the Pomc/
background. The 10-kb transgene contains regulatory el-
ements that rescue transcription of Pomc to skin structures
as well as pituitary cells of the compound mutant mice.
Lastly, we also tested possible transcription of the Pomc-
ps1 pseudogene using RT-PCR with the expected negative
results (Fig. 7).
Discussion
We have demonstrated that nonagouti 129;B6 POMC-
deficient mice are skin negative for mRNA corresponding to
either the Pomc or Pomc-ps1 genes, but their hair follicle
development, structure, and melanin pigmentation are
similar to control 129;B6 Pomc/ and inbred wild-type
C57BL/6J mice. Therefore, 129;B6 Pomc/mice can produce
eumelanin hair pigmentation despite a total absence of local
and systemic MSH or ACTH ligands.
These findings are significant because MSH and ACTH
are recognized as major regulators of melanin pigmentation
in rodents and humans (13, 15, 16). Melanocortin peptide
FIG. 3. Histology of the skin and hair follicles from experimental mice. The skin architecture and morphology of adnexal structures are
similar in Pomc/ (A, C, and E) and Pomc/ (B, D, and F) mice. A and B, Skin with hair follicles at telogen phase. C and D, Skin with
hair follicles at anagen V phase of hair growth. E and F, Detailed structures of anagen hair follicles (left) and hair shafts (insets, right)
for Pomc/ (E) and Pomc/ (F) mice. Two arrows, epidermis; D, dermis; SG, sebaceous gland; HF, hair follicle. Bar (A–D), 160 m;
(E and F), 40 m.
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effects are mediated through a signal cascade that includes
ligand interactions with the stimulatory G protein-coupled
MC1-R, activation of cAMP-dependent pathways, and stim-
ulation or induction of eumelanogenesis (13, 15, 49). The
eumelanogenic pathway is counteracted by AGP, both a
functional antagonist of melanocortins and an inverse ago-
nist at MC1-R, which inhibits expression and activity of
melanogenesis-related proteins, melanogenic enzymes, and
MC1-R, thereby inducing the switch from eu- to pheomela-
nogenesis (3, 26, 27, 31). It is important to note that the switch
between pheo- to eumelanogenesis in normal agouti fur is of
a discontinuous on or off character-pheomelanin usually
produced in low amounts at low levels of tyrosinase activity,
whereas pure eumelanin is generated over a threshold value
of tyrosinase activity (50). Eumelanosomes also differ in
structure and shape from pheomelanosomes (1, 3, 51). It is
FIG. 5. Quantitative analysis of the EPR measurements. A, Integral intensities of the EPR signals of analyzed materials. B, Peak-to-peak line
widths of the EPR signals. All the bars represent means  SEM of five independent samples (except Pomc/ and yellow gerbil, n  16 and
6 samples, respectively) of powdered substance (8.1 mg, synthetic melanins) or dry fur (20 mg). Parameters of assay of the integral signal
intensities: microwave power, 1 mW; modulation amplitude, 5 Gs; gain, 12,500; parameters of assay of the signal line widths: microwave power,
1 mW; modulation amplitude, 0.5 Gs; see also Materials and Methods.
FIG. 4. Typical EPR spectra of syn-
thetic (powder samples of 8.1 mg) and
naturalmaterials (dry fur samples of 20
mg) containing various contributions of
pheomelanin. Left panel, Dopa mela-
nin, a synthetic eumelanin-like pig-
ment with a singlet, slightly asymmet-
ric line; cysteinyldopa, the synthetic
counterpart of pheomelanin with a
characteristic 14N hyperfine splitting
(arrows, the low-field line, thick arrow,
are better pronounced than the high-
field line, thin arrow). Right panel,
Characteristic hyperfine splitting (ar-
rows) was present only in the EPR spec-
tra of yellow fur from Ay/a mice and
yellow gerbils and absent in all the ho-
mogenously black fur from Pomc/,
Pomc/, and standard C57BL/6Jmice.
Insert, Macrophotos of fur samples cor-
responding to the spectra on the right.
DPPH, Position of free radical signal of
DPPH. Parameters of assay, modula-
tion amplitude 2 Gs; microwave power
1 mW; received gains of 12,500 (dopa
melanin), 62,000 (cysteinyldopa mela-
nin), 40,000 (Pomc/), 25,000 (Pomc/
and C57BL/6J a/a), 800,000 (C57BL/6J
AY/a), and 1 million (yellow gerbil); see
also Materials and Methods.
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therefore highly unlikely that low amounts of pheomelanin
in the absence of AGP expression are generated in parallel to
the ongoing eumelanogenesis in the same melanosome and at
the same time. If the quality ofmelanogenesiswas changeddue
to the deletion of POMC in our model, it should have resulted
in a drastic reduction of the total amount of pigment, such that
the presence of the EPR signal features attributed to pheomela-
nin would be detectable. In fact, the absence of POMC did not
result in a qualitative change ofmelanogenesis, comparedwith
the parental C57BL/6J mice as measured by EPR spectroscopy
and morphologic and histological examinations.
It is probable that the eumelanogenic phenotype in the
129;B6 Pomc/ mice is due to a relatively high basal (i.e.
ligand-independent) activity of MC1-R based on the follow-
ing considerations: 1) MC1-R can be stimulated to couple to
G proteins and stimulate the production of intracellular
cAMP independently from its peptide agonists, i.e. by metal
ions (52); 2) basal activity of MC1-R increases directly with
greater receptor number (in malignant melanocytes) (53); 3)
MC1-R expression is hair cycle dependent with the highest
expression levels at anagen V-VI (when the melanogenic
activity reaches its peak) and lowest at telogen (resting
phase) (37); 4) MC1-R variants strongly correlate with the
type and degree of melanin production throughout the an-
imal kingdom (54); and 5) AGP (an intrinsic inhibitor of
MC1-R activity) was absent or very low (12, 26, 27).
Therefore, the presumed event that prevents the switch
from eu- to pheomelanogenesis in 129;B6 Pomc/mice is the
lack or very low concentration of AGP dictated by the (a/a)
genotype (12, 26, 27). In turn, this would allow maintenance
of eumelanin synthesis through high basal ligand-indepen-
dent or stimulated MC1-R activity (see above) and appears
to be consistent with the hypothesis of a bimodal switch
regulating the passage from eu- to pheomelanogenesis (50).
Stimulatory signals could also be provided by factors acting
at the postreceptor level (MC1-R-independent pathways),
either by directly raising intracellular cAMP levels or by
stimulating protein kinaseA; intracellular second-messenger
pathways critical for melanogenesis in rodents (49, 55). This
postulation of multiple regulatory points of melanogenesis,
i.e. direct regulation through receptor mediated or metabolic
action on melanocytes and indirect through stimulation of
other cellular targets, which in turn release biologic regula-
tors or simply change the chemical environment of melano-
cytes is consistent with current concepts of melanin produc-
tion (51). The process is thought to be redundant and
determined by multiple regulatory factors including a time-
frame and spatial-temporal dependence on both feedback
and feed-forward controls in place from embryonic to adult
life (51). The heterogeneous and redundant nature of
proeumelanogenic signals explains why the deletion of only
one, but a very important, regulatory factor (the agonist
ligands for theMC1-R) is not sufficient to produce a dramatic
FIG. 6. Amplification of mouse Pomc gene products by nested RT-
PCR. Exons 2 and 3 were amplified from cDNA with sets of primer
pairs P327/P326 and P328/P330 (A) or P328/P326 and P329/P330 (B).
Lane 1, Mouse skin Pomc/ (total RNA); lane 2, mouse skin
Pomc/ (mRNA); lane 3, mouse skin Pomc/ (total RNA); lane 4,
mouse skin Pomc/ (mRNA); lane 5, anagen mouse skin Pomc/
(mRNA); lane 6, telogenmouse skinPomc/ (mRNA); lane 7, anagen
mouse skin Pomc/ (mRNA); lane 8, telogen mouse skin Pomc/
(mRNA); lane 9, anagen mouse skin Pomc/ (mRNA); lane 10, telo-
gen mouse skin Pomc/ (mRNA); lane 11, telogen skin from the
Pomc transgene rescue mouse (mRNA). Primer pairs P329/P326 and
P325/P330 from exon 3 were used to amplify cDNA (C) or RNA (D)
without prior RT (RT, negative control). Lane 1, Anagen skin Pomc/
mRNA); lane 2, telogen skin Pomc/ (mRNA); lane 3, anagen skin
Pomc/ (mRNA); lane4, telogenskinPomc/ (mRNA); lane5, telogen
skin from the Pomc transgene rescue mouse (mRNA).
FIG. 7. Amplification of mousePomc-ps1 pseudogene putative products
by PCR. A, Amplification of Pomc-ps1 pseudogene with primer pair
P331/P332. B, Amplification of GAPDH (positive control). DNase-
treated mRNA was used for RT in all samples with the exception of
genomic DNA in lane 1. Lane 1, Genomic DNA; lane 2, mouse skin
Pomc/; lane 3, mouse skin Pomc/; lane 4, mouse anagen skin
Pomc/; lane 5, mouse telogen skin Pomc/; lane 6, mouse anagen
skin Pomc/; lane 7, mouse telogen skin Pomc/; lane 8, mouse
anagen skinPomc/; lane 9,mouse telogen skinPomc/; and lane 10,
telogen skin from the Pomc transgene rescue mouse (mRNA).
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change of melanogenesis in a predominantly C57BL/6 ge-
netic background.
Previously published studies indicated that mammalian
MC1-Rs can exhibit agonist-independent, constitutive activity
in vitro. One of the first reports (56) used the amelanotic mouse
melanoma cell line B16-G4F stably transfected with the human
MC1-R. More recently the human MC1-R was shown to con-
stitutively activate cAMP production in transfected, heterolo-
gous human embryonic kidney 293T, HeLa, and Chinese ham-
ster ovary cell lines in addition to overexpression in HBL
human melanoma cell lines (57). Importantly, the latter study
also demonstrated significant constitutive activity of themouse
MC1-R in transfected human embryonic kidney 293T cells. The
intrinsic signaling activity of mouse MC1-R was lower than
human MC1-R at similar binding site densities, but the two
species exhibited comparable augmentation of forskolin-medi-
ated cAMP production (57).
Many other G protein-coupled receptors demonstrate sig-
nificant constitutive activity (58, 59). Particularly relevant is
the finding that both MC3-R and MC4-R have high levels of
basal signaling revealed by the inverse agonist activity of
agouti-gene-related protein (60). Similarly the endogenous
cannibinoid receptors CB1 and CB2 (61, 62), the angiotensin
II receptor (63), and several classes of 5-hydroxytryptamine
receptors are constitutively active (64, 65). In other cases,
such as the mu opioid receptor, prolonged agonist exposure
appears to induce constitutive activity in the subsequent
absence of ligand (66) and activating mutations can readily
be introduced into this and many other G protein-coupled
receptors. Notable examples of spontaneous mutations lead-
ing to clinical disorders from agonist-independent receptor
activation include the TSH receptor associated with thyro-
toxicosis (67) and the LH receptor leading to precocious
puberty (68). Therefore, ample precedents support the con-
cept of high basal activity of the MC1-R in the absence of
melanocortin peptide stimulation.
Within the context of the above, the present findings donot
contradict the previous concept of induction of a mild
pheomelanin-like phenotype in homozygous Pomc/ mice
on a hybrid agouti 129 genetic background that was reverted
by MSH treatment (34). Thus, genetic background repre-
sented, i.e. by the presence or absence of AGP, would take
priority over the regulatory role of MSH or ACTH in mel-
anogenesis. This is consistent with the current concept pro-
posing that melanogenesis-controlling factors are not ar-
ranged in simple linear sequences; instead they interact in a
multidimensional network, with extensive overlapping and
diversity of factors acting in a stochastic fashion determined
by the genetic-biochemical-physical context (51).
In summary, we demonstrate that deletion of the Pomc gene
in nonagouti 129;B6 mice does not significantly reduce total
melanin production or induce a switch to pheomelanogenesis.
We suggest that the phenotype results from ligand-indepen-
dent activation of MC1-R, which triggers and sustains eumela-
nogenesis in vivo. This mechanism is consistent with published
reports of constitutiveMC1-R activity in transfected cell lines in
vitro, oftenpositively correlatedwith increased receptordensity
per cell, but does not necessarily imply a paramount role in
melanogenesis under normal physiological conditions. Our
data do not exclude the possibility that genetic deletion of
melanocortin ligands has a stimulatory effect on MC1-R sig-
naling by either increases in receptor number or intrinsic ac-
tivity, and this in turn contributed to the lack of any change in
fur pigmentation. Additionally, redundant nonmelanotropic
pathway(s) may be recruited to ensure eumelanin pigmenta-
tion in theabsenceofbothmelanocortinpeptidesandAGP.One
example of an alternative paracrine pathway could involve
TRH, which has been demonstrated to bind and activate the
MC1-R with low micromolar affinity and to be synthesized in
hair follicle papilla fibroblasts (69, 70). Overall, our findings
serve to reinforce theconclusion, thatdespite theoverwhelming
dominance of POMC-derived peptides in the stimulation of
melanogenesis, skin and hair pigmentation are complex, poly-
genic traits (51).
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